Bone Growth Stimulator Market is projected to exhibit a CAGR of 5.30%, with an estimated worth of US$ 3.33 Billion by year 2032 end | PMR

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡'𝐬 𝐒𝐭𝐮𝐝𝐲, 𝐭𝐡𝐞 𝐁𝐨𝐧𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟓.𝟑𝟎% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. 𝐓𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐯𝐚𝐥𝐮𝐞 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟐.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐭𝐨 𝐔𝐒𝐃 𝟑.𝟑𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐. 𝐓𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐠𝐫𝐨𝐰𝐭𝐡 𝐢𝐬 𝐩𝐫𝐢𝐦𝐚𝐫𝐢𝐥𝐲 𝐟𝐮𝐞𝐥𝐞𝐝 𝐛𝐲 𝐭𝐡𝐞 𝐫𝐢𝐬𝐢𝐧𝐠 𝐢𝐧𝐜𝐢𝐝𝐞𝐧𝐜𝐞𝐬 𝐨𝐟 𝐛𝐨𝐧𝐞-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐢𝐧𝐣𝐮𝐫𝐢𝐞𝐬 𝐚𝐧𝐝 𝐟𝐫𝐚𝐜𝐭𝐮𝐫𝐞𝐬. 𝐁𝐞𝐬𝐢𝐝𝐞𝐬, 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐝𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐧𝐨𝐧-𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐚𝐫𝐞 𝐬𝐮𝐩𝐩𝐨𝐫𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

Bone growth stimulator, commonly abbreviated as BGS, is a form of therapy often used to promote healing after a spinal fusion surgery. Put simply, a bone growth stimulator is a device that acts as constant-current source to encourage bone growth. It may make use of ultrasonic or pulsed electric waves. There are two main types of bone growth stimulators in the market, which include internal bone growth stimulators and external bone growth stimulators.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.polarismarketresearch.com/industry-analysis/bone-growth-stimulator-market/request-for-sample

Internal stimulators are surgically implanted within the body, whereas external stimulators are portable devices meant to be worn outside the body. To be effective, bone growth stimulators need to be worn every day. Bone growth stimulators are used by hospitals, home care and academic and research institutes for spinal fusion surgeries, non-union bone fractures, and oral & maxillofacial surgeries.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

• MEDTRONIC PLC.
• DJO Global
• STRYKER CORPORATION
• JOHNSON and JOHNSON
• Essex Woodlands Healthcare Partners (Bioventus LLC)
• Isto Biologics
• IGEA Pharma
• THERAGEN ETEX CO. LTD
• Manamed Inc
• Arthrex
• Terumo Corporation
• Orthofix Medical Inc.
• ZIMMER BIOMET HOLDINGS

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

• The bone growth stimulator market segmentation is primarily based on product type, application, end use and region.

• By product type analysis, the bone growth stimulation devices accounted for the highest revenue share as they're an important part of the market.

• By application analysis, the spinal fusion surgeries segment dominated the market owing to rising incidence of spinal disorders.

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞 :
• Bone Growth Stimulation Devices
o External Bone Growth Stimulators
o Ultrasonic Bone Growth Stimulators
o Implanted Bone Growth Stimulators
𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧
• Spinal Fusion Surgeries
• Delayed union & Non-union Bone Fractures
• Oral & Maxillofacial Surgeries

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/2029/2

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐁𝐨𝐧𝐞 𝐆𝐫𝐨𝐰𝐭𝐡 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• The bone growth stimulation devices segment accounted for the highest revenue share due to the increasing prevalence of orthopedic conditions and sports injuries and the growing use of bone growth stimulation devices.

• The spinal Fusion Surgeries segment dominated the market in 2022, mainly driven by a rising incidence of spinal disorders, such as degenerative disc disease and spinal stenosis, which is driving the growth of the spinal fusion surgeries segment.

• The hospital & ambulatory surgical centers segment held a significant market share and is likely to continue its dominance over the anticipated period due to the increasing demand for minimally invasive surgeries and the cost-effectiveness of outpatient procedures.

• North America accounted for the largest market share in 2022 and is likely to maintain its dominance over the projected period due to the presence of key market players, increasing healthcare expenditure, growing patient awareness, and increasing the number of bone disorders.

• The global key market players include THERAGEN ETEX CO., LTD, Manamed Inc, Arthrex, Terumo Corporation, Orthofix Medical Inc., Essex Woodlands Healthcare Partners (Bioventus LLC), Isto Biologics, IGEA Pharma ZIMMER BIOMET HOLDINGS, MEDTRONIC PLC., DJO Global, STRYKER CORPORATION, JOHNSON, and JOHNSON.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐀𝐝𝐝𝐢𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐞𝐭𝐚𝐢𝐥𝐬 : https://www.polarismarketresearch.com/industry-analysis/bone-growth-stimulator-market

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
𝗧𝗿𝗮𝗻𝘀𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/transfection-technologies-market
𝗗𝗲𝗻𝘁𝗮𝗹 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁: https://www.polarismarketresearch.com/industry-analysis/dental-laboratories-market
𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/infectious-disease-diagnostic-market
𝗢𝗽𝗵𝘁𝗵𝗮𝗹𝗺𝗶𝗰 𝗗𝗿𝘂𝗴𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/ophthalmic-drug-market
𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗙𝗼𝗼𝗱𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://www.polarismarketresearch.com/industry-analysis/medical-foods-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.